PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
PHASE2
Background:
One way to treat liver cancer is to deliver chemotherapy drugs...
Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases
PHASE2
Approximately 40% of colorectal cancer patients will develop colorectal liv...
Status
Unknown
Location
Severance Hospital, Yonsei University Health System
A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy
PHASE2
First line chemotherapy treatment regimens for metastatic colorectal cancer...
Status
Unknown
Location
Associació Catalana per la Recerca Oncològica i les Seves Implicacions Sanitaries i Socials
FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema
PHASE4
The purpose of this interventional study is to assess the progression free ...